Legend Biotech Corp (LEGN)

28.45 -1.86  -6.14% NASDAQ Apr 9, 20:00 USD
View Full Chart
Price Chart
View All LEGN News


View All Events


Date Type Description
08/28/2020 00:00 Earnings Results Q2 2020 Earnings Results
11/16/2020 00:00 Earnings Results Q3 2020 Earnings Results
03/18/2021 00:00 Earnings Results Q4 2020 Earnings Results
03/18/2021 08:00 EDT Earnings Calls Q4 2020 Earnings Call
08/27/2021 00:00 Earnings Results Q2 2021 Earnings Results
03/18/2022 08:00 Earnings Calls Q4 2021 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL: https://www.legendbiotech.com
  • Investor Relations URL: N/A
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Aug. 27, 2021
  • Last Earnings Release: Mar. 18, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from North America.

Top Fund Holders

Symbol Name Weighting
CNCR Loncar Cancer Immunotherapy ETF 3.70%
SBIO ALPS Medical Breakthroughs ETF 2.96%
MASGX Matthews Asia ESG Investor 1.99%
CHNA Loncar China BioPharma ETF 1.87%
REFGX Capital Group Emerging Markets Gr R-6 1.18%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.